Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Other Operating Expenses (2016 - 2025)

China Pharma Holdings filings provide 16 years of Other Operating Expenses readings, the most recent being $82313.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses fell 53.11% to $82313.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $374768.0, a 29.89% decrease, with the full-year FY2025 number at $374768.0, down 29.89% from a year prior.
  • Other Operating Expenses hit $82313.0 in Q4 2025 for China Pharma Holdings, down from $103343.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $440734.0 in Q2 2021 to a low of $82313.0 in Q4 2025.
  • Median Other Operating Expenses over the past 5 years was $173953.5 (2022), compared with a mean of $194479.6.
  • Biggest five-year swings in Other Operating Expenses: tumbled 78.75% in 2021 and later soared 30.05% in 2022.
  • China Pharma Holdings' Other Operating Expenses stood at $286280.0 in 2021, then grew by 23.75% to $354261.0 in 2022, then decreased by 24.35% to $267996.0 in 2023, then plummeted by 34.5% to $175527.0 in 2024, then tumbled by 53.11% to $82313.0 in 2025.
  • The last three reported values for Other Operating Expenses were $82313.0 (Q4 2025), $103343.0 (Q3 2025), and $103324.0 (Q2 2025) per Business Quant data.